Turnbull Biotech ApS: Financial statements 2024
CVR: 43491938
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Turnbull Biotech ApS (CVR 43491938) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -51,241 and a net result of DKK 166,587. Equity in the 2024 report amounted to DKK 493,056. The solvency ratio was 95.4%.
- Gross Profit
- DKK -51,241
- Profit/Loss
- DKK 166,587
- Equity
- DKK 493,056
- Total Assets
- DKK 516,778
- Employees
- 0
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Turnbull Biotech ApS has published its interim report for the period September 5, 2022 to December 31, 2023.
About Turnbull Biotech ApS
Turnbull Biotech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jordan Philip Turnbull. The company is owned by Jordan Philip Turnbull. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -71,508 and a net result of DKK -241,233 compared with DKK 166,587 the year before. Equity in the 2025 report amounted to DKK 251,823.
